Justin Walsh
Stock Analyst at Jones Trading
(3.36)
# 954
Out of 5,245 analysts
40
Total ratings
43.24%
Success rate
25.33%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience | Maintains: Buy | $49 → $44 | $21.22 | +107.35% | 2 | Apr 2, 2026 | |
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $9 | $3.69 | +143.90% | 1 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Downgrades: Hold | n/a | $103.00 | - | 11 | Feb 27, 2026 | |
| ATAI AtaiBeckley | Initiates: Buy | $16 | $4.32 | +270.37% | 1 | Dec 23, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $83 | $343.56 | -75.84% | 1 | Sep 18, 2025 | |
| VNRX VolitionRx | Initiates: Buy | $60 | $3.13 | +1,816.93% | 1 | Jun 10, 2025 | |
| BLRX BioLineRx | Upgrades: Buy | $12 | $3.06 | +292.16% | 3 | May 30, 2025 | |
| CLNN Clene | Initiates: Buy | $30 | $6.70 | +347.76% | 1 | Apr 23, 2025 | |
| MNPR Monopar Therapeutics | Downgrades: Hold | n/a | $63.12 | - | 1 | Apr 2, 2025 | |
| SER Serina Therapeutics | Initiates: Buy | $11 | $1.98 | +455.56% | 1 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $37.72 | +11.35% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $3.98 | +452.76% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $3.26 | +390.80% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.69 | +326.44% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $4 | $0.4608 | +768.06% | 4 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.97 | +573.40% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $14.33 | +2,412.21% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,875 | $6.59 | +28,352.20% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $20 | $33.00 | -39.39% | 1 | May 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $440 → $200 | $0.5012 | +39,804.23% | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.07 | +383.09% | 1 | Jan 19, 2022 |
Alto Neuroscience
Apr 2, 2026
Maintains: Buy
Price Target: $49 → $44
Current: $21.22
Upside: +107.35%
NeuroOne Medical Technologies
Mar 2, 2026
Initiates: Buy
Price Target: $9
Current: $3.69
Upside: +143.90%
Lantheus Holdings
Feb 27, 2026
Downgrades: Hold
Price Target: n/a
Current: $103.00
Upside: -
AtaiBeckley
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $4.32
Upside: +270.37%
Praxis Precision Medicines
Sep 18, 2025
Initiates: Buy
Price Target: $83
Current: $343.56
Upside: -75.84%
VolitionRx
Jun 10, 2025
Initiates: Buy
Price Target: $60
Current: $3.13
Upside: +1,816.93%
BioLineRx
May 30, 2025
Upgrades: Buy
Price Target: $12
Current: $3.06
Upside: +292.16%
Clene
Apr 23, 2025
Initiates: Buy
Price Target: $30
Current: $6.70
Upside: +347.76%
Monopar Therapeutics
Apr 2, 2025
Downgrades: Hold
Price Target: n/a
Current: $63.12
Upside: -
Serina Therapeutics
Mar 11, 2025
Initiates: Buy
Price Target: $11
Current: $1.98
Upside: +455.56%
Oct 18, 2024
Initiates: Buy
Price Target: $42
Current: $37.72
Upside: +11.35%
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $3.98
Upside: +452.76%
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $3.26
Upside: +390.80%
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $4.69
Upside: +326.44%
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.4608
Upside: +768.06%
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $2.97
Upside: +573.40%
May 16, 2023
Initiates: Buy
Price Target: $360
Current: $14.33
Upside: +2,412.21%
Oct 7, 2022
Initiates: Buy
Price Target: $1,875
Current: $6.59
Upside: +28,352.20%
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $33.00
Upside: -39.39%
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $0.5012
Upside: +39,804.23%
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $2.07
Upside: +383.09%